APR, in line with its prominent vision of expanding a global partner network, will participate to the 9th BIO-Europe Spring® conference (Paris, Mar 9-11 2015), a flagship event for the health biotechnology sector.
APR thanks to its innovative business model and network of international partners has a proven track record in developing branded and patented Rx and OTC products worldwide in selected therapeutic areas on a global basis and offers late-stage licensing opportunities, among those:
Nexodyn™, the super-oxidized spray solution that improves functional conditions of the physiological wound healing process, representing a new treatment option of acute and chronic wound management.
Halykoo™, the first global pediatric brand dedicated to the baby healthcare needs from birth to childhood. A breakthrough market-ready products portofolio combining advanced technology, state-of the art formulations and innovative delivery systems tailored on moms and babies’ needs.
We look forward to meeting you at BIO!